THE ROLE OF PATHOGENETIC THERAPY IN PRESERVING EJACULATE FERTILITY IN PATIENTS WITH TUBERCULOSIS OF PROSTATE


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Introduction: Genital tuberculosis impairs male reproductive function. Given that tuberculosis of the prostate has been found at autopsy in 77% of men who died of tuberculosis of all locations, the problem is highly relevant. Aim: To develop and test a method of restoring/preserving fertility in patients with prostatic tuberculosis and to evaluate its effectiveness. Material and methods: TThis is an open, prospective, comparative, randomized study, comprising 72 patients with prostatic tuberculosis. Patients of the main group (n=49) received standard TB treatment in combination with pathogenetic spermatoprotective therapy including zinc and selenium based dietary supplement and chorionic gonadotropin. The men in the comparison group (n=23) were treated only with etiotropic TB therapy. Results: TB treatment had a negative effect on the ejaculate: in the comparison group a two-month course of drug therapy resulted in a decrease in sperm cell count by 23.9%, in the number of actively motile sperm cells by 10.6% and in the number of normal sperm cells by 32.3%. Pathogenetic spermatoprotective therapy increased the sperm cell count by 47.8%, the number of active mobile forms of spermatozoa (total of A and B) by 40.5%, the number of normal sperm cells by 41.9%. Conclusions: Spermatoprotective therapy, including human chorionic gonadotropin and zinc and selenium based dietary supplement significantly increases the ejaculate fertility.

全文:

受限制的访问

作者简介

E. Kulchavenya

Novosibirsk Tuberculosis Research Institute of Minzdrav of Russia; Novosibirsk State Medical University of Minzdrav of Russia

Email: urotub@yandex.ru
Dr.Med.Sc., Principal Researcher; Prof. at the Department of Tuberculosis

A. Osadchii

Novosibirsk Tuberculosis Research Institute of Minzdrav of Russia

Email: urotub@yandex.ru

参考

  1. Кульчавеня Е.В., Брижатюк Е.В., Хомяков В.Т. Туберкулез экстраторакальных локализаций в Сибири и на Дальнем Востоке. Туберкулез и болезни легких. 2005;6:23-25
  2. Кульчавеня Е.В., Брижатюк Е.В., Ковешникова Е.Ю., Свешникова Н.Н. Новые тенденции в эпидемической ситуации по туберкулезу экстраторакальных локализаций в Сибири и на Дальнем Востоке. Туберкулез и болезни легких. 2009;10:27-31
  3. Жукова И.И., Кульчавеня Е.В., Холтобин Д.П., Брижатюк Е.В., Хомяков В.Т., Осадчий А.В. Туберкулез мочеполовой системы сегодня. Урология. 2013;1:13-16
  4. Goodarzi D., Cyrus A., Baghinia M.R., Kazemifar A.M., Shirincar M. The efficacy of zinc for treatment of chronic prostatitis. Acta Med Indones. 2013;45(4):259-264.
  5. Ludwig M., Dimitrakov J., Diemer T., Huwe P., Weidner W. Prostatitis syndrome. Changes in the ejaculate and effects on fertility. Urologe A. 2001;40(1):18-23.
  6. Cai T., Wagenlehner F.M., Mondaini N., D’Elia C., Meacci F., Migno S., Malossini G., Mazzoli S., Bartoletti R. Effect of human papillomavirus and Chlamydia trachomatis co-infection on sperm quality in young heterosexual men with chronic prostatitis-related symptoms. BJU Int. 2014;113(2):281-7. doi: 10.1111/bju.12244. Epub 2013 Jul 26.
  7. Ivanov I.B., Gritsenko V.A., Kuzmin M.D. Phenotypic differences between coagulase-negative staphylococci isolated from seminal fluid of healthy men and men suffering from chronic prostatitis syndrome. Int J Androl. 2010;33(3):563-7. doi: 10.1111/j.1365-2605.2009.00969.x.
  8. Dohle G.R. Inflammatory-associated obstructions of the male reproductive tract. Andrologia. 2003;35(5):321-324.
  9. Zhao H., Shen J.H., Chen Y.P., Yu Z.Y, Dong Q, Li H. Changes of seminal parameters, zinc concentration and antibacterial activity in patients with non-inflammatory chronic prostatitis/chronic pelvic pain syndrome. Zhonghua Nan Ke Xue. 2008;14(6):530-532.
  10. Flibotte J.J., Lee G.E., Buser G.L., Feja K.N., Kreiswirth B.N., McSherry G.D., Nolan S.M., Tolan R.W. Jr, Zhang H. Infertility, in vitro fertilization and congenital tuberculosis. J Perinatol. 2013;33(7):565-8. doi: 10.1038/jp.2012.146.
  11. Perletti G., Marras E., Wagenlehner F.M., Magri V. Antimicrobial therapy for chronic bacterial prostatitis. Cochrane Database Syst Rev. 2013;8:CD009071. doi: 10.1002/14651858.CD009071.pub2.
  12. Yanushpolsky E.H., Politch J.A., Hill J.A., Anderson D.J. Is leukocytospermia clinically relevant? Fertil Steril. 1996; 66(5):822-825.
  13. Domes T, Lo K.C., Grober E.D., Mullen J.B., Mazzulli T., Jarvi K. The incidence and effect of bacteriospermia and elevated seminal leukocytes on semen parameters. Fertil Steril. 2012;97(5):1050-5. doi: 10.1016/j.fertnstert.2012.01.124. Epub 2012 Feb 16
  14. Кульчавеня Е.В., Неймарк А.И. Простатит. Диагностика и лечение: руководство. М.:ГЭОТАР-Медиа. 2010;256 с. ил. (Библиотека врача-специалиста)
  15. Kulchavenya E. Best practice in the diagnosis and management of Urogenital Tuberculosis. 2013;5(3):143-51. doi: 10.1177/1756287213476128
  16. Кульчавеня Е.В., Бреусов А.А. Эффективность уро-ваксома при рецидивирующих инфекционно-воспалительных заболеваниях мочеполовой системы. Урология. 2011;4:7-11
  17. Mirone M., Giannetta E., Isidori A.M. Selenium and reproductive function. A systematic review. J Endocrinol Invest. 2013; 36(10):28-36.
  18. Walczak-Jedrzejowska R., Wolski J.K., Slowikowska-Hilczer J. The role of oxidative stress and antioxidants in male fertility. Cent European J Urol. 2013;66(1):60-7. doi: 10.5173/ceju.2013.01.art19.
  19. Мохирева Л.В., Богадельникова И.В. Биологическая роль цинка в организме человека. Туберкулез и болезни легких. 2011;7:3-10
  20. Lombardo F., Fiducia M., Lunghi R., Marchetti L., Palumbo A., Rizzo F., Koverech A., Lenzi A., Gandini L. Effects of a dietary supplement on chronic pelvic pain syndrome (Category IIIA), leucocytospermia and semen parameters. Andrologia. 2012;44(1):672-8. doi: 10.1111/j.1439-0272.2011.01248.x. Epub 2011 Nov 7.
  21. Witkowska-Zimny M., Gunerka A., Wietrak E., Poludniewski G., Lew-Starowicz Z. Verification of the effectiveness of the dietary supplementation in infertility treatment. Pol Merkur Lekarski. 2013;35(210):347-351.
  22. Сивков А.В., Ощепков В.Н., Евдокимов В.В., Кешишев Н.Г., Шкабко О.В. Применение препарата Селцинк Плюс у больных хроническим неинфекционным простатитом и нарушениями фертильности. Урология. 2011;5:27-33

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2016
##common.cookie##